Northland Age
  • Northland Age home
  • Latest news
  • Sport
  • Rural
  • Opinion
  • Kaitaia weather

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • Sport
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology

Locations

  • Far North
  • Kaitaia
  • Kaikohe
  • Bay of Islands
  • Whangārei

Weather

  • Kaitaia
  • Whangārei
  • Dargaville

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In

Advertisement
Advertise with NZME.
Home / Northland Age

Letters: Missing out on cancer drugs

Northland Age
11 Oct, 2017 11:30 PM3 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

Medsafe is one of the best agencies in the world at registering new medicine, says a reader.

Medsafe is one of the best agencies in the world at registering new medicine, says a reader.

Cancer touches all New Zealanders in some way, and the number of cancer diagnoses is on the rise, with one in three of us likely to be diagnosed in our lifetime.

Giving hope in the fight to beat cancer, new immunotherapy medicines are emerging with better survival data than we've seen before. Yet, because of New Zealand's strict system for funding, many of these essential new medicines are not currently available to all who need them.

As New Zealanders, we should be challenging the new government to ensure cancer is seen as a priority, not only in terms of faster access to specialists and treatment, but also faster access to the most effective medicines. Patients may be getting diagnosed more quickly, but in many cases they are being given treatments that have been superseded in most other countries.

Medsafe is one of the best agencies in the world at registering new medicines. Medsafe's appraisal and approval timelines are consistent with other global regulators, such as the European and Australian agencies.

However, New Zealand is the only OECD country with a capped pharmaceutical budget, and while Pharmac does its best within the existing budget, the trade-off is lack of access to new medicines. A study by Professor Frank Lichtenberg noted that between 2006 and 2010 about 12 per cent of deaths from cancer within five years from diagnosis would have been avoided if cancer survival in New Zealand was the same as Australia.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

Every new tumour type must go through the same time-consuming application, committee review, potential re-application, ranking and negotiation process. This leads to long delays and no guarantee of eventual funding. Currently, the average wait time for Pharmac funding is over three years.

Things are very different overseas. For example, in Germany medicines are funded immediately upon registration, followed by a formal reimbursement process that is concluded within one year.

Other countries in Europe have recognised immunotherapies' significant potential to treat multiple cancers, and have taken specific steps to ensure timely access for their citizens.

Advertisement
Advertise with NZME.

Closer to home, Australian Health Minister Greg Hunt announced recently that he had asked the Pharmaceutical Benefits Advisory Committee (Australia's Pharmac equivalent) to "find a way" to assess cancer medicines that treat multiple tumours, to help ensure timely patient access.

During the election campaign the New Zealand First Party included a policy to conduct a review of the efficiency and efficacy of Pharmac's operations, and of the adequacy of pharmaceutical funding.

The Labour Party pledged to immediately begin work on an early access to medicines scheme that will give patients access to innovative life-saving new medicines.

The National Party has increased the funding to Pharmac over its term in government.

It appears that all parties have in some way recognised that there is work to be done to improve access to medicines. A boost to the Pharmac budget of just $40 per person, and the introduction of a mechanism for rapid access to break-through new medicines, would mean we truly would have a world-class system for medicines funding in New Zealand.

PAUL SMITH
NZ director, Merck Sharp & Dohme (New Zealand)

Save

    Share this article

Latest from Northland Age

Northland Age

'Public safety at risk': Guns, cannabis found in Kaitāia raid

Northland Age

Prisoners gain skills building homes for families in need

Northland Age

Far North news in brief: NRC weed workshops, 64 sika deer culled


Sponsored

Solar bat monitors uncover secrets of Auckland’s night sky

Advertisement
Advertise with NZME.

Latest from Northland Age

'Public safety at risk': Guns, cannabis found in Kaitāia raid
Northland Age

'Public safety at risk': Guns, cannabis found in Kaitāia raid

Police found three .22 rifles, a shotgun and a semi-automatic rifle at a Kaitāia house.

16 Jul 10:53 PM
Prisoners gain skills building homes for families in need
Northland Age

Prisoners gain skills building homes for families in need

16 Jul 07:00 PM
Far North news in brief: NRC weed workshops, 64 sika deer culled
Northland Age

Far North news in brief: NRC weed workshops, 64 sika deer culled

16 Jul 04:00 PM


Solar bat monitors uncover secrets of Auckland’s night sky
Sponsored

Solar bat monitors uncover secrets of Auckland’s night sky

06 Jul 09:47 PM
NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • The Northland Age e-edition
  • Manage your print subscription
  • Manage your digital subscription
  • Subscribe to Herald Premium
  • Subscribe to The Northland Age
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • The Northland Age
  • The New Zealand Herald
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP